Marc Schneebaum, C.P.A.
Description On May 24, 2010, the Board of Directors appointed Mark O. Thornton, M.D., M.P.H., Ph.D as its Senior Vice President, Development and Chief Medical Officer. Dr. Thornton, 52, was with Genvec, Inc. from October 2006 to May 2010, where he served as Senior Vice-President, Product Development. Prior to that, Dr. Thornton served as Managing Director, Clinical and Regulatory Affairs for Angiotech Pharmaceuticals, Inc. during 2005 and 2006. From 2004 to 2005, Dr. Thornton was Chief Medical Officer for ZioPharm Oncology, Inc. He was employed as a Medical Officer at various branches of the U.S. Food and Drug Administration from 1995 until 1997, and again from 1999 to 2004. From 1997 until 1999 he was a Director of Clinical Research at Otsuka America Pharmaceutical, Inc. To view the detailed information, you need to SUBSCRIBE with us. |
 |